(19)

(11)

EP 4 558 166 A1

(12)

(43) Date of publication: 28.05.2025 Bulletin 2025/22 (21) Application number: 23755273.2 (22) Date of filing: 20.07.2023

(51) International Patent Classification (IPC):  A61K 39/00(2006.01) C07K 16/18(2006.01) A61K 39/395(2006.01) (52) Cooperative Patent Classification (CPC): C07K 16/18; C07K 2317/24; A61K 39/00; A61P 25/28; A61P 25/00; A61K 39/39591 (86) International application number: PCT/US2023/070540 (87) International publication number: WO 2024/020470 (25.01.2024 Gazette 2024/04)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA Designated Validation States: KH MA MD TN (30) Priority: 21.07.2022 US 202263369033 P (71) Applicant: Eli Lilly and Company Indianapolis, IN 46285 (US)	(72) Inventors: CORVARI, Vincent John Indianapolis, IN 46206-6288 (US) DURBIN, Nicole H. Indianapolis, IN 46206-6288 (US) SHARMA, Anant Navanithan Indianapolis, IN 46206-6288 (US) (74) Representative: Eli Lilly and Company Limited  8 Arlington Square West Downshire Way Bracknell Berkshire RG12 1PU Bracknell Berkshire RG12 1PU (GB)